Mrs Renee Allison, - Pharmacist in Las Cruces, NM

Mrs Renee Allison, is a Pharmacist based in Las Cruces, New Mexico. Mrs Renee Allison is licensed to practice in New Mexico (license number 5695) and her current practice location is 3331 Rinconada Blvd, Las Cruces, New Mexico. She can be reached at her office (for appointments etc.) via phone at (575) 680-3779.

NPI number for Mrs Renee Allison is 1003215112 and her current mailing address is 3331 Rinconada Blvd, Las Cruces, New Mexico. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1003215112.

Contact Information

Mrs Renee Allison,
3331 Rinconada Blvd,
Las Cruces, NM 88011-7193
(575) 680-3779
Not Available

Healthcare Provider's Profile

Full NameMrs Renee Allison
GenderFemale
SpecialityPharmacist
Location3331 Rinconada Blvd, Las Cruces, New Mexico
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1003215112
  • Provider Enumeration Date: 08/14/2014
  • Last Update Date: 08/14/2014

Medical Identifiers

Medical identifiers for Mrs Renee Allison such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003215112NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist 5695 (New Mexico)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Renee Allison is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mrs Renee Allison,
3331 Rinconada Blvd,
Las Cruces, NM 88011

Ph: (575) 680-3779
Mrs Renee Allison,
3331 Rinconada Blvd,
Las Cruces, NM 88011-7193

Ph: (575) 680-3779

News Archive

Data from FAME Phase 3 study for Iluvien presented at Angiogenesis 2010

pSivida Corp., a leader in the development of ophthalmic sustained release drug delivery products, with two of the only three such products approved by the FDA for treatment of back of the eye diseases, today said that 24-month data from the FAME Phase 3 study for Iluvien presented at Angiogenesis 2010 included additional efficacy and safety data that reinforced the positive top-line results reported in December 2009 by pSivida and its licensee, Alimera Sciences, Inc.

Novel gene therapy treatment proves safe, effective for factor VII deficiency

A single injection. That's all someone with a factor VII deficiency would need for a life-long cure, thanks to a new gene therapy treatment developed in a collaboration of researchers at the University of North Carolina and The Children's Hospital of Philadelphia.

Number of HIV-positive cancer patients in the U.S. projected to decrease through 2030

As the population of people living with HIV in the United States ages, the burden of cancer for these patients is expected to shift away from cancers linked to AIDS and toward malignancies that affect the general population, according to a new study led by a University of North Carolina at Chapel Hill researcher.

Merck announces publication of GARDASIL pivotal Phase III study data in NEJM

Merck announced today that data from the pivotal Phase III study with GARDASIL in males were published in the February 3 issue of the New England Journal of Medicine.

CHF signs agreement with Global Fund to implement HIV/AIDS program in Colombia

CHF International, the Silver Spring-MD based international development and humanitarian assistance organization, announced it signed an agreement with the Global Fund to Fight AIDS, Tuberculosis and Malaria to implement a two-year HIV and AIDS program in Colombia, with the possibility to extend it for another three years.

Read more News

› Verified 3 days ago


Pharmacist in Las Cruces, NM

Dale Menges, RPHD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1600 Thorpe Rd, Las Cruces, NM 88012
Phone: 505-382-6812    
Lynda Caroline Ralston,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1256 El Paseo Rd, Las Cruces, NM 88001
Phone: 575-525-8713    Fax: 575-541-8561
Min Bae,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1900 Bataan Memorial E # Lc, Las Cruces, NM 88011
Phone: 575-522-8603    
Dr. Jennifer Morales, PHARM D
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 3490 Northrise Dr, Las Cruces, NM 88011
Phone: 575-382-9100    
Wesley Dixon, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1600 Thorpe Rd, Las Cruces, NM 88012
Phone: 505-382-6812    
Eva Kamianowski, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 3490 Northrise Dr, Las Cruces, NM 88011
Phone: 575-382-9100    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.